ZYDUSLIFE — Zydus Lifesciences Share News
0.000.00%
- IN₹1.19tn
- IN₹1.30tn
- IN₹271.48bn
Brief: Zydus Lifesciences Unit Buys 100% Of Aptitude Orthopedie, France
Brief: Zydus Lifesciences Says Subsidiary Has Been Incorporated In Name Of Zara Merger Sub Inc
Brief: Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
Indian pharma stocks rise as Nomura flags strong March sales
Brief: Zydus Lifesciences Receives EIR For Oncology Injectable Manufacturing Facility In SEZ1, Ahmedabad
Focus: Patients scramble to find estrogen patches as shortage worsens after US FDA champions use
Brief: Zydus Lifesciences Receives Final USFDA Approval For Dapagliflozin Tablets
Brief: Zydus Lifesciences Says Tax Demand Of 41.77 Million Rupees Dropped
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation
Brief: Zydus Lifesciences Receives Demand Order For FY 2019-20 To FY 2023-24
Brief: Zydus Lifesciences Receives Tax Demand Penalty Of 32.8 Mln Rupees
UBS initiates Indian pharma coverage amid weight-loss drug opportunity
India drug regulator tightens surveillance against unauthorised weight-loss drug sales (updated)
Factbox: Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy
Analysts upbeat on semaglutide opportunity as patent expiry triggers India generics
Brief: Zydus Lifesciences Launches Semaglutide Injection In Reusable Multi-Dose Pen Device In India, Priced At 2,200 Rupees Per Month
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
Brief: Zydus Lifesciences Launches Aerolife Mini, To Simplify Inhaler Use For Asthma And COPD Patient
Marketing Innovative Semaglutide Injection In India